Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets | Business Wire
Teva- Pharmaceutical Industries Ltd. - ADR Stock Forecast: down to 7.941 USD? - TEVA Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Teva Pharmaceutical Gets a Quantitative Upgrade to Hold - RealMoney
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical: The Babe Ruth of the Investment World (NYSE:TEVA) | Seeking Alpha